Anaphylaxis upon switching lipid-containing amphotericin B formulation.
Cronin
J E
JE
Barron
R L
RL
D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects*; D000707:Anaphylaxis / Q000209:etiology*; D002626:Chemistry, Pharmaceutical; D006801:Humans; D008055:Lipids / Q000008:administration & dosage
D008055:Lipids; D000666:Amphotericin B